Table 5.
Risk Score (6-Point Scoring System) | Risk Classification | ||||||
---|---|---|---|---|---|---|---|
Total Points | Patients (n = 95) * |
AEF | Rate of AEF (%) | Risk Category | Patients | AEF | Rate of AEF, % (95% CI) |
0 | 10 | 0 | 0.0 | Low risk | 46 | 2 | 4.3(0.5–14.8) |
1 | 13 | 0 | 0.0 | ||||
2 | 23 | 2 | 8.7 | ||||
3 | 35 | 6 | 17.1 | High risk | 49 | 12 | 24.5(13.3–38.9) |
4 | 11 | 5 | 45.5 | ||||
5 | 2 | 1 | 50.0 | ||||
6 | 1 | 0 | 0.0 |
AEF: arterial–esophageal fistula; 95% CI: 95% confidence interval; HEARTS-score consists of hematemesis, active bleeding, renal function (serum creatinine level > 1.2 mg/dL), prothrombin time > 13 s, previous stent implantation; low risk is defined as a HEARTS-Score of 0–2 points, while high risk is defined as a HEARTS-Score of 3–6 points. * There were missing data in seven cases.